Obiettivo - Poor glucose control in critically ill patients leads to significant increases in costs, complication and mortality rates. Continuous monitoring of glucose will reduce costs of €2700 per patient and could save 58 000 lives in the EU every year.- GlucoSet has developed a disposable glucose sensor for monitoring glucose in the ICU. The sensor measures glucose by measuring sub-nanometer length changes in an advanced material that responds to the glucose level. The product is designed for mass-manufacturing at its core. The innovative fiber optic sensor is protected by granted patents and has freedom to operate. The sensor will be sold as a single-use device lasting 96h with a gross margin of over 90% at high volume. - The total addressable market (US and EU) is $1600 million per year. Willingness to pay has already been confirmed. The project has strong backing from key opinion leaders.- Unlike the competition, the sensor couples to the indwelling arterial catheter, which enables unsurpassed reliability and ease of use.- The SMEi phase 2 will take the project from working prototypes that have been tested in vivo, to a CE-marked device. We expect market entry in 2021 in the EU.- The company has a very strong team that has extensive experience with medical devices, scaling up production and raising and working with venture capital. Campo scientifico scienze socialisociologiademografiamortalitàscienze mediche e della salutemedicina di basefarmacologia e farmaciafarmaciscienze mediche e della salutemedicina clinicaendocrinologiadiabeteingegneria e tecnologiaingegneria elettrica, ingegneria elettronica, ingegneria informaticaingegneria elettronicasensoriscienze naturaliscienze fisicheotticafibra ottica Programma(i) H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme H2020-EU.3. - PRIORITY 'Societal challenges H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies Argomento(i) EIC-SMEInst-2018-2020 - SME instrument Invito a presentare proposte H2020-EIC-SMEInst-2018-2020 Vedi altri progetti per questo bando Bando secondario H2020-SMEInst-2018-2020-2 Meccanismo di finanziamento SME-2 - SME instrument phase 2 Coordinatore GLUCOSET AS Contribution nette de l'UE € 2 376 150,00 Indirizzo Sluppenvegen 6 7037 Oslo Norvegia Mostra sulla mappa PMI L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione. Sì Regione Norge Trøndelag Trøndelag Tipo di attività Private for-profit entities (excluding Higher or Secondary Education Establishments) Collegamenti Contatta l’organizzazione Opens in new window Partecipazione a programmi di R&I dell'UE Opens in new window Rete di collaborazione HORIZON Opens in new window Altri finanziamenti € 3 992 257,50
